Literature DB >> 3777429

Purification of human serum vitamin D-binding protein by 25-hydroxyvitamin D3-Sepharose chromatography.

R P Link, K L Perlman, E A Pierce, H K Schnoes, H F DeLuca.   

Abstract

25-Hydroxyvitamin D3-Sepharose was prepared by coupling 25-hydroxyvitamin D3-3 beta-(1,2-epoxypropyl)-ether to thio-activated Sepharose CL-6B, forming a protease-resistant linkage between the sterol and the matrix. Vitamin D-binding protein from human plasma was obtained 85-92% pure after ligand affinity chromatography. Subsequent hydroxylapatite chromatography provided homogeneous protein. The purified vitamin D-binding protein was fully active in regard to 25-hydroxyvitamin D3 and actin binding capabilities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777429     DOI: 10.1016/0003-2697(86)90624-x

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.

Authors:  N Yamamoto; V R Naraparaju
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

2.  Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.

Authors:  M Korbelik; V R Naraparaju; N Yamamoto
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

4.  Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin.

Authors:  N Yamamoto; R Kumashiro; M Yamamoto; N P Willett; D D Lindsay
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

5.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Authors:  Nobuto Yamamoto; Hirofumi Suyama; Nobuyuki Yamamoto
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

6.  Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP).

Authors:  J Arnaud; J Constans
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

7.  Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity.

Authors:  Evgeniya V Dolgova; Svetlana S Kirikovich; Evgeniy V Levites; Vera S Ruzanova; Anastasia S Proskurina; Genrikh S Ritter; Oleg S Taranov; Nikolay A Varaksin; Tatiana G Ryabicheva; Olga Yu Leplina; Alexandr A Ostanin; Elena R Chernykh; Sergey S Bogachev
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

8.  Simple method for large-scale production of macrophage activating factor GcMAF.

Authors:  Yoko Nabeshima; Chiaki Abe; Takeshi Kawauchi; Tomoko Hiroi; Yoshihiro Uto; Yo-Ichi Nabeshima
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.